Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utidelone injection in second-line failed advanced or metastatic colorectal cancer
CTR20200403Phase 2Active
- Sponsor
- Biostar Pharmaceuticals
- Start
- Mar 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of utidelone in colorectal cancer (CRC), sponsored by Biostar Pharmaceuticals. Started Mar 2020; status: active.
02
Drugs
utidelone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20200403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200403.